[Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement].
The efficiency and safety of use of enoxaparin (clexane Rhone-Poulenc Rorer) in antithrombotic prophylaxis after total hip replacement is presented. The subcutaneous dose of 40 mg daily proved to be highly efficient and of minor side-effects.